24/7 Customer Support

Organoids And Spheroids Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2031

Global Organoids And Spheroids Market: By Type (Organoids, Spheroids); Method (Organoids, Spheroids); Source (Organoids, Spheroids); Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing); End-User (Biotechnology and pharmaceutical industries, Academic & Research Institutes, Hospitals and diagnostic centers); Region— Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2023–2031

  • Published On: 17-Apr-2023  |   Format: pdfpowerpointexcel  |  Report ID: AA0423418
    Delivery: 2 to 4 Hours
Organoids And Spheroids Market

View Full Infographic


Report AttributeDetails
Market Size Value in 2022US$ 771.4 Million
Expected Revenue in 2031US$ 4,567.0 Million
Historic Data2018-2021
Base Year2022
Forecast Period2023-2031
UnitValue (USD Mn)
Segments coveredBy Type, By Method, By Source, By Application, By End User, By Region
Key Companies                                                                                                                       3D BioMatrix, 3D Biotek LLC, AMS Biotechnology (Europe) Limited, ATCC, Cellesce Ltd, Corning Incorporated, Greiner Bio-One, Hubrecht Organoid Technology (HUB), InSphero/Perkin Elmer, Kuraray, Lonza, Merck KGaA, Prellis Biologics, STEMCELL Technologies Inc., Thermo Fisher Scientific, Inc., Other Prominent Players.
Customization ScopeGet your customized report as per your preference. Ask for customization


The Global organoids and spheroids market is expected to grow with CAGR of 22.42% during forecast period 2023-2031 and is expected to reach USD 4567.02 million by 2031. 

Factors such as developments in the 3D spheroid technology and rise in the adoption of organoid cultures in drug discovery boost the market growth.

Advancements in the high throughput cell culture systems are the current trends in organoids and spheroids market.

Adequate research funding in medical science provides the favourable growth opportunity in the organoids and spheroids market.

North America is dominating the market by holding the largest share in the Global organoids and spheroids market.

Asia Pacific is expected to grow with the highest CAGR during the forecast period.

United States is accounting majority of the market share in North America region.

The Global organoids and spheroids market is segmented in by type, method, source, application, end user.

Source segment holds the largest share during the forecast period.

Based on source Organoids hold the largest share in the market.

The organoids and spheroids market was negligibly affected by covid-19 pandemic.

Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, Merck KGAA among all others.